Results 131 to 140 of about 5,560 (153)

Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapy

Journal of Cancer Research and Clinical Oncology, 2023
Milad Moloudizargari, Shirin Hekmatirad, Sajjad Gharaghani, A. Moghadamnia, Hossein Najafzadehvarzi, M. Asghari   +5 more
semanticscholar   +1 more source

Aprepitant

Reactions Weekly, 2014
openaire   +1 more source

The impact of Aprepitant on Nausea and Vomiting following Laparoscopic Sleeve Gastrectomy: A Blinded Randomized Controlled Trial

Obesity Surgery
Elías Ortiz, Alberto I González, Valeria Jaime, José A Guzmán, Isaac Esparza, José O Orozco, Manuel A Guerrero, Almino Ramos, C. Zerrweck   +8 more
semanticscholar   +1 more source

Aprepitant (EMEND)

Journal Of Pain & Palliative Care Pharmacotherapy, 2005
openaire   +1 more source

Aprepitant

2010
openaire   +1 more source

Aprepitant/Voriconazole

Reactions Weekly, 2018
openaire   +1 more source

Aprepitant/erlotinib

Reactions Weekly, 2011
openaire   +1 more source

Aprepitant/ifosfamide

Reactions Weekly, 2018
openaire   +1 more source

Aprepitant

2013
openaire   +1 more source

Aprepitant/cyclophosphamide interaction

Reactions Weekly, 2022
openaire   +1 more source